Skip to content

CVRx, Inc. CVRX Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

Neuropace, Inc. logo
Neuropace, Inc.NPCE
$0+100%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$331K-1,224%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$67K+23.0%
Neuronetics logo
NeuroneticsSTIM
-$270K
ITG
Integer HoldingsITGR
$0-100%
VAN
Vivani MedicalVANI
-$15K+50.4%

Other financials

Income statement

See full
Revenue$14.8M+19.6%
Gross profit$12.9M+24.9%
Operating income-$12.2M+9.5%
Net income-$13.1M+4.7%
EPS (diluted)-$0.50+5.7%

Balance sheet

See full
Cash & equivalents$72.3M-29.6%
Total debt$59.4M+17.8%
Total equity$29.1M-58.0%
Total assets$99.7M-23.0%

Cash flow

See full
Operating cash flow-$12.2M+4.7%
CapEx$122.0K+7.0%
Free cash flow-$12.3M+4.6%

Valuation

See full
Market cap$148.6M-2.9%
Enterprise value$135.69M+25.0%
P/S2.5×-0.3×

Profitability

See full
Gross margin86.2%+2.7pp
Operating margin-84.6%-8.9pp
Net margin-89.1%-7.0pp
FCF margin-68%-8.1pp

Returns & leverage

See full
Return on equity-107%+73.4pp
Debt / equity+1.3×
Current ratio10.2×-4.6×

Where this comes from

Reported directly by CVRx, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.

The official record: CVRx, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVRx, Inc.'s gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVRx, Inc.'s gain/loss on asset sales?
CVRx, Inc. (CVRX) reported gain/loss on asset sales of -$1K in Q1 2026.
What does gain/loss on asset sales mean?
Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.